Get the Stockscreener App
0.1887
6.12%
-0.0123
Arcadia Biosciences Inc stock is traded at $0.1887, with a volume of 485.24K.
It is down -6.12% in the last 24 hours and down -56.21% over the past month.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
See More
Previous Close:
$0.201
Open:
$0.1829
24h Volume:
485.24K
Relative Volume:
0.08
Market Cap:
$454.62K
Revenue:
$4.76M
Net Income/Loss:
$-9.32M
P/E Ratio:
-0.033
EPS:
-5.7182
Net Cash Flow:
$-4.25M
1W Performance:
-31.03%
1M Performance:
-56.21%
6M Performance:
-86.42%
1Y Performance:
-96.54%
1-Day Range:
$0.1822
$0.195
1-Week Range:
$0.1593
$0.2892
52-Week Range:
$0.1593
$5.72
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Name
Arcadia Biosciences Inc
Sector
Industry
Phone
214-974-8921
Address
5956 SHERRY LANE, DALLAS, CA
Compare RKDA vs JBS, KHC, GIS, SJM, MKC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
0.1887 | 454.62K | 4.76M | -9.32M | -4.25M | -5.7182 |
JBS
Jbs Nv
|
12.95 | 42.61B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
23.25 | 27.57B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
33.16 | 17.73B | 18.42B | -85.30M | 1.63B | -0.1894 |
SJM
J M Smucker Co
|
125.38 | 13.39B | 9.05B | -138.70M | 1.16B | -1.307 |
MKC
Mccormick Co Inc
|
46.32 | 12.46B | 7.39B | 1.63B | 1.02B | 6.0085 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-20 | Reiterated | H.C. Wainwright | Buy |
| May-12-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-09-15 | Initiated | Credit Suisse | Outperform |
| Jun-09-15 | Initiated | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Stock (RKDA) Latest News
Arcadia Biosciences stock stays below Nasdaq's USD 1 threshold - ad-hoc-news.de
Arcadia Biosciences Company Profile & Introduction - Moomoo
Arcadia Biosciences approves reverse split plan affecting RKDA stock - ad-hoc-news.de
Arcadia Biosciences stock faces a Nasdaq compliance test - ad-hoc-news.de
Arcadia Biosciences Inc (RKDA-Q) Stock Price and News - The Globe and Mail
Voting power over 378,740 shares is shared by three Arcadia Biosciences (RKDA) holders. - Stock Titan
Arcadia Biosciences stock faces a Nasdaq compliance deadline - AD HOC NEWS
Arcadia Biosciences stock falls 20.21 percent on Nasdaq risks - AD HOC NEWS
Arcadia Biosciences stock reacts to shareholder approval of capital changes - AD HOC NEWS
Arcadia Biosciences stock reacts to shareholder approval of capital measures - AD HOC NEWS
Arcadia Biosciences Inc (NASDAQ: RKDA) Share Price, RKDA Stock News, RKDA Share Price & Updates - Kalkine
Form 8K Arcadia Biosciences Inc For: 15 September By Investing.com - Investing.com Canada
Arcadia Biosciences stockholders approve reverse stock split and new equity plan - Investing.com
Director at Arcadia (RKDA) gets 10K options at $0.46 - Stock Titan
Arcadia Biosciences (RKDA) grants director options at $0.46 - Stock Titan
Gregory Waller granted 10K Arcadia (RKDA) options at $0.46 - Stock Titan
Arcadia Biosciences (RKDA) director gets 10,000 stock options - Stock Titan
Arcadia Biosciences Inc Annual Shareholders Meeting Transcript - GuruFocus
Is Arcadia Biosciences (NASDAQ:RKDA) Facing A Tougher Market Test? - kalkinemedia.com
Arcadia Biosciences stock faces Nasdaq listing pressure after equity shortfall - ad-hoc-news.de
Arcadia Biosciences Receives Nasdaq Listing Compliance Notice - The Globe and Mail
Arcadia Biosciences Faces Nasdaq Delisting After Equity Falls to $633,000 - minichart.com.sg
Arcadia Biosciences Receives Nasdaq Listing Compliance Notice - TipRanks
Arcadia Biosciences Disclosed Failure to Satisfy a Continued Listing Rule or Standard - tradingview.com
Arcadia Biosciences (RKDA) Edges Slightly Lower to $0.47 as Trading Range TightensFear Greed Index - careplusvn.com
Arcadia Biosciences stock holds steady as investors look to next earnings signals - ad-hoc-news.de
Arcadia Biosciences Inc. (RKDA) Key Financial Ratios – Valuation, Profitability & More - Value Research
Arcadia Biosciences stock trades at $0.52 as market cap slips to $1.28 million - ad-hoc-news.de
Arcadia Biosciences Inc. (RKDA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Arcadia Biosciences (RKDA) Gains 1.63% as Shares Hold Above Key SupportHull Moving Average - careplusvn.com
Arcadia Biosciences (RKDA) Gains 1.63% as Shares Hold Above Key SupportEquity Put Call - dars.gov.et
Arcadia (RKDA) Technicals: Moves 5.00% Higher to $0.48 in Latest Trading; Market Levels: Price Remains Between $0.46 Support and $0.50 Resistance on the DayMean Reversion Trade - vinanet.vn
Arcadia (RKDA) Latest: Rises 1.55% to $0.46 on the Day; Level Watch: the Current Price Sits Inside the Supplied Technical Range in the Current UpdateRetail Driven Moves - vinanet.vn
Arcadia (RKDA) Update: Slides 0.22% to $0.45 for the Current Session; Current Setup: the Current Price Sits Inside the Supplied Technical Range in Latest TradingETF AUM Growth - vinanet.vn
Arcadia (RKDA) Latest: Adds 4.99% to Close at $0.44; Trading Range: the Session Ends Within the Reported Technical Boundaries under the Current SnapshotFactor Crowding - vinanet.vn
Armistice Capital (RKDA holder) discloses 9.99% beneficial stake in Arcadia Biosciences - Stock Titan
RKDA|Arcadia Biosciences Inc|Price:0.632|Chg%:+0.008 - TradingKey
Arcadia Biosciences earnings missed by $1.53, revenue fell short of estimates - Investing.com Canada
Arcadia Biosciences Q2 EPS improves to $(2.09) as sales dip 1% - scanx.trade
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com - Investing.com Nigeria
Arcadia Biosciences : Announces Second Quarter and First Half 2026 Financial Results and Business Highlights - marketscreener.com
Arcadia Biosciences: Q2 Earnings Snapshot - AOL.com
Arcadia Biosciences: Q2 Earnings Snapshot - Enidnews.com
Arcadia Biosciences: Q2 Earnings Snapshot - KTVB
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com - Investing.com India
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com - Investing.com Canada
Form 8K Arcadia Biosciences Inc For: 13 August By Investing.com - Investing.com UK
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights - Yahoo Finance
Arcadia Biosciences, Inc. (RKDA) Debt 2025 - Stock Titan
Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights - globenewswire.com
Arcadia Biosciences Inc Stock (RKDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.50%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):